Join our email list to stay up to date on the latest Amyloidosis news.

The American Society of Nuclear Cardiology is hosting a series of virtual symposiums to address the knowledge, competence and performance gaps in disease epidemiology, pathophysiology, diagnosis and treatments for ATTR-CM.

Speakers include Sarah Cuddy, MD, BCh, Frederick Ruberg, MD, Sharmila Dorbala, MD, MPH, Rodney Falk, MD and more.

The Cardiac Amyloidosis: On the Road programs will:

  • Address the knowledge, competence and performance gaps in disease epidemiology, pathophysiology, diagnosis and treatments for ATTR-CM.
  • Improve diagnosis across all patient populations, timely referral to amyloid experts, and knowledge of treatment options with the goal of improving outcomes of patients with ATTR-CM.
  • Enhance the understanding of the overlap of cardiac amyloidosis with other conditions leading to a misdiagnosis or delayed diagnosis.
  • Focus on the diagnostic algorithm, including the appropriate use of Tc-99m PYP, and the importance of image interpretation alongside other clinical findings.
  • Discuss the central role of Tc-99m PYP imaging and the protocols for acquisition, processing and interpretation to ensure understanding of the procedure and the data it provides.

Participants of these programs will be able to:

  • Describe amyloidosis, including specific types, cardiac features and disease burden.
  • Identify barriers to identification and diagnosis of patients suspected of ATTR.
  • Recognize patients at risk for hereditary ATTR (hATTR) and wild-type ATTR (wtATTR).
  • Summarize the diagnostic evaluation for cardiac amyloidosis including the differential diagnosis.
  • Provide details of Tc-99m PYP including imaging protocol, semi-quantitative and quantitative scoring, interpretation including identifying false positive and false negative studies, and components of an appropriate report.
  • Demonstrate understanding of current treatments for patients with ATTR-CM.

Fee: ​Free for members, $75 for non-members

Credits: Earn 3.0* AMA PRA Category 1 Credits™​ 
*Credits subject to change

*

*

*

*